{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:27:44Z","timestamp":1773923264485,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00345-017-2051-3","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T06:56:16Z","timestamp":1495781776000},"page":"1669-1680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Jue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiande","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"2051_CR1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-5347(17)63130-6","volume":"97","author":"PD Zimskind","year":"1967","unstructured":"Zimskind PD, Fetter TR, Wilkerson JL (1967) Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 97:840\u2013844","journal-title":"J Urol"},{"key":"2051_CR2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-5347(17)57613-2","volume":"119","author":"TW Hepperlen","year":"1978","unstructured":"Hepperlen TW, Mardis HK, Kammandel H (1978) Self-retained internal ureteral stents: a new approach. J Urol 119:731\u2013734","journal-title":"J Urol"},{"key":"2051_CR3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.juro.2014.10.123","volume":"193","author":"J Fiuk","year":"2015","unstructured":"Fiuk J, Bao Y, Calleary JG, Schwartz BF, Denstedt JD (2015) The use of internal stents in chronic ureteral obstruction. J Urol 193:1092\u20131100","journal-title":"J Urol"},{"key":"2051_CR4","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.juro.2016.05.109","volume":"196","author":"VM Pais Jr","year":"2016","unstructured":"Pais VM Jr, Smith RE, Stedina EA, Rissman CM (2016) Does omission of ureteral stents increase risk of unplanned return visit? A systematic review and meta-analysis. J Urol 196:1458\u20131466","journal-title":"J Urol"},{"key":"2051_CR5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0090-4295(01)01644-2","volume":"59","author":"HB Joshi","year":"2002","unstructured":"Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG (2002) Characterization of urinary symptoms in patients with ureteral stents. Urology 59:511\u2013516","journal-title":"Urology"},{"key":"2051_CR6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.ju.0000048980.33855.90","volume":"169","author":"HB Joshi","year":"2003","unstructured":"Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169:1065\u20131069","journal-title":"J Urol"},{"key":"2051_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000443379","volume":"97","author":"SE Staubli","year":"2016","unstructured":"Staubli SE, Mordasini L, Engeler DS, Sauter R, Schmid HP, Abt D (2016) Economic aspects of morbidity caused by ureteral stents. Urol Int 97:91\u201397","journal-title":"Urol Int"},{"key":"2051_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.eururo.2005.06.006","volume":"48","author":"R Damiano","year":"2005","unstructured":"Damiano R, Autorino R, De Sio M, Sacco R, D\u2019Armiento M (2005) Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 48:673\u2013678","journal-title":"Eur Urol"},{"key":"2051_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13311","author":"P Betschart","year":"2017","unstructured":"Betschart P, Zumstein V, Piller A, Schmid HP, Abt D (2017) Prevention and treatment of symptoms associated with indwelling ureteral stents: a systematic review. Int J Urol. doi:\n                        10.1111\/iju.13311","journal-title":"Int J Urol"},{"key":"2051_CR10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.juro.2010.06.043","volume":"184","author":"A Dellis","year":"2010","unstructured":"Dellis A, Joshi HB, Timoney AG, Keeley FX Jr (2010) Relief of stent related symptoms: review of engineering and pharmacological solutions. J Urol 184:1267\u20131272","journal-title":"J Urol"},{"key":"2051_CR11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1464-410X.2011.10170.x","volume":"108","author":"AD Lamb","year":"2011","unstructured":"Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ (2011) Meta-analysis showing the beneficial effect of \u03b1-blockers on ureteric stent discomfort. BJU Int 108:1894\u20131902","journal-title":"BJU Int"},{"key":"2051_CR12","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"issue":"15","key":"2051_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"2007","author":"Beverley J Shea","year":"2007","unstructured":"Shea Beverley J, Grimshaw Jeremy M, Wells George A et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007(15):10","journal-title":"BMC Med Res Methodol"},{"key":"2051_CR14","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"2051_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00240-013-0554-y","volume":"41","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Huang KH, Yang HJ, Chang HC, Chen J, Yang TK (2013) Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis 41:247\u2013252","journal-title":"Urolithiasis"},{"key":"2051_CR16","doi-asserted-by":"crossref","first-page":"752382","DOI":"10.1155\/2013\/752382","volume":"2013","author":"E Shalaby","year":"2013","unstructured":"Shalaby E, Ahmed AF, Maarouf A, Yahia I, Ali M, Ghobish A (2013) Randomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-J stent-related lower urinary symptoms. Adv Urol 2013:752382","journal-title":"Adv Urol"},{"key":"2051_CR17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00345-015-1544-1","volume":"33","author":"J Park","year":"2015","unstructured":"Park J, Yoo C, Han DH, Shin DW (2015) A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent related symptoms: a 2\u00a0\u00d7\u00a02 factorial randomized trial. World J Urol 33:1833\u20131840","journal-title":"World J Urol"},{"key":"2051_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.aju.2016.01.004","volume":"14","author":"AM Abdelaal","year":"2016","unstructured":"Abdelaal AM, Al-Adl AM, Abdelbaki SA, Al Azab MM, Al Gamal KA (2016) Efficacy and safety of tamsulosin oral-controlled absorption system, solifenacin, and combined therapy for the management of ureteric stent-related symptoms. Arab J Urol 14:115\u2013122","journal-title":"Arab J Urol"},{"key":"2051_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12894-016-0186-y","volume":"16","author":"Q Liu","year":"2016","unstructured":"Liu Q, Liao B, Zhang R, Jin T, Zhou L, Luo D, Liu J, Li H, Wang K (2016) Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms\u2014outcome from a randomized controlled trial. BMC Urol 16:66","journal-title":"BMC Urol"},{"key":"2051_CR20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00345-015-1704-3","volume":"34","author":"AR El-Nahas","year":"2016","unstructured":"El-Nahas AR, Tharwat M, Elsaadany M, Mosbah A, Gaballah MA (2016) A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms. World J Urol 34:963\u2013968","journal-title":"World J Urol"},{"key":"2051_CR21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.aju.2016.08.004","volume":"14","author":"IA Hekal","year":"2016","unstructured":"Hekal IA (2016) Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: a contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience. Arab J Urol 14:262\u2013268","journal-title":"Arab J Urol"},{"key":"2051_CR22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/end.2016.0663","volume":"31","author":"AE Dellis","year":"2017","unstructured":"Dellis AE, Papatsoris AG, Keeley FX Jr, Bamias A, Deliveliotis C, Skolarikos AA (2017) Tamsulosin, solifenacin, and their combination for the treatment of stent-related symptoms: a randomized controlled study. J Endourol 31:100\u2013109","journal-title":"J Endourol"},{"key":"2051_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1988-y","author":"MH Abdelhamid","year":"2017","unstructured":"Abdelhamid MH, Zayed AS, Ghoneima WE, Elmarakbi AA, El Sheemy MS, Aref A, Abdelbary A, Nour HH (2017) Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospiumchloride in the relief of double-J stent-related symptoms. World J Urol. doi:\n                        10.1007\/s00345-016-1988-y","journal-title":"World J Urol"},{"key":"2051_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-017-1561-7","author":"M Ragab","year":"2017","unstructured":"Ragab M, Soliman MG, Tawfik A, Abdel Raheem A, El-Tatawy H, Abo Farha M, Magdy M, Elashry O (2017) The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial. Int Urol Nephrol. doi:\n                        10.1007\/s11255-017-1561-7","journal-title":"Int Urol Nephrol"},{"key":"2051_CR25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/end.2016.0129","volume":"30","author":"C Koprowski","year":"2016","unstructured":"Koprowski C, Kim C, Modi PK, Elsamra SE (2016) Ureteral stent-associated pain: a review. J Endourol 30:744\u2013753","journal-title":"J Endourol"},{"key":"2051_CR26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/01.ju.0000049198.53424.1d","volume":"169","author":"HB Joshi","year":"2003","unstructured":"Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG (2003) Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 169:1060\u20131064","journal-title":"J Urol"},{"key":"2051_CR27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.juro.2011.04.061","volume":"186","author":"R Yakoubi","year":"2011","unstructured":"Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P (2011) Is there a role for \u03b1-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol 186:928\u2013934","journal-title":"J Urol"},{"key":"2051_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1958-4","author":"Y Tanidir","year":"2016","unstructured":"Tanidir Y, Mangir N, Sahan A, Sulukaya M (2016) Turkish version of the ureteral stent symptoms questionnaire: linguistic and psychometric validation. World J Urol. doi:\n                        10.1007\/s00345-016-1958-4","journal-title":"World J Urol"},{"key":"2051_CR29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4111\/kju.2011.52.7.485","volume":"52","author":"KT Lim","year":"2011","unstructured":"Lim KT, Kim YT, Lee TY, Park SY (2011) Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 52:485\u2013488","journal-title":"Korean J Urol"},{"key":"2051_CR30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/end.2014.0715","volume":"29","author":"L Zhou","year":"2015","unstructured":"Zhou L, Cai X, Li H, Wang KJ (2015) Effects\u00a0of \u03b1-blockers,\u00a0antimuscarinics, or\u00a0combination therapy\u00a0in\u00a0relieving\u00a0ureteral\u00a0stent-related\u00a0symptoms: a\u00a0meta-analysis. J Endourol 29:650\u2013656","journal-title":"J Endourol"},{"key":"2051_CR31","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1464-410X.2008.07939.x","volume":"102","author":"Linda Cardozo","year":"2008","unstructured":"Cardozo Linda, He\u00dfd\u00f6rfer Elke, Milani Rodolfo et al (2008) Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial. BJU Int 102:1120\u20131127","journal-title":"BJU Int"},{"key":"2051_CR32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1067\/mem.2001.118863","volume":"38","author":"EJ Gallagher","year":"2001","unstructured":"Gallagher EJ, Liebman M, Bijur PE (2001) Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med 38:633\u2013638","journal-title":"Ann Emerg Med"},{"key":"2051_CR33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","volume":"93","author":"CR Chapple","year":"2004","unstructured":"Chapple CR, Rechberger T, Al-Shukri S et al (2004) Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int 93:303\u2013310","journal-title":"BJU Int"},{"key":"2051_CR34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.2010.09482.x","volume":"107","author":"G Giannarini","year":"2011","unstructured":"Giannarini G, Keeley FX Jr, Valent F, Manassero F, Mogorovich A, Autorino R, Selli C (2011) Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated ureteric stent symptoms questionnaire. BJU Int 107:648\u2013654","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-017-2051-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2051-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2051-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T08:31:15Z","timestamp":1508488275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-017-2051-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2051"],"URL":"https:\/\/doi.org\/10.1007\/s00345-017-2051-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]}}}